Intuitive Surgical (NASDAQ:ISRG) Cut to Hold at Wall Street Zen

Intuitive Surgical (NASDAQ:ISRG) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday.

Other equities analysts have also recently issued reports about the stock. Royal Bank Of Canada set a $625.00 price target on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Argus upped their target price on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Evercore ISI increased their price target on Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Finally, Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. Two analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $607.17.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $575.34 on Friday. The firm has a market capitalization of $206.25 billion, a PE ratio of 76.10, a PEG ratio of 5.23 and a beta of 1.68. The stock’s fifty day moving average is $518.60 and its 200 day moving average is $505.69. Intuitive Surgical has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period in the previous year, the firm earned $1.84 earnings per share. Intuitive Surgical’s quarterly revenue was up 22.9% compared to the same quarter last year. Equities analysts forecast that Intuitive Surgical will post 6.43 EPS for the current year.

Insider Activity

In related news, EVP Myriam Curet sold 105 shares of the business’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $560.00, for a total value of $58,800.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the transaction, the executive vice president directly owned 3,056 shares in the company, valued at approximately $1,772,480. This trade represents a 81.80% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 108,939 shares of company stock valued at $60,757,995. Insiders own 0.70% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several institutional investors and hedge funds have recently made changes to their positions in ISRG. Tobam increased its position in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares during the period. Kilter Group LLC purchased a new stake in shares of Intuitive Surgical in the 2nd quarter worth approximately $27,000. Princeton Global Asset Management LLC bought a new position in shares of Intuitive Surgical during the second quarter valued at approximately $30,000. TD Capital Management LLC increased its holdings in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the period. Finally, Greykasell Wealth Strategies Inc. bought a new position in Intuitive Surgical in the third quarter worth approximately $27,000. 83.64% of the stock is currently owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.